Related Experiment Videos
Impaired prepubertal uterine responsivity after neonatal exposure to steroid hormone esters
Insights
Neonatal exposure to estradiol benzoate (EB) or testosterone propionate (TP) impairs uterine development and responsiveness in rats. This effect is linked to reduced estrogen receptor availability and ovarian weight, highlighting estrogen's role in uterine conditioning.
Area of Science:
- Endocrinology
- Developmental Biology
- Reproductive Science
Background:
- Neonatal exposure to hormones can have long-lasting effects on reproductive organ development.
- Estrogen plays a critical role in uterine growth and function.
Purpose of the Study:
- To investigate the impact of neonatal exposure to estradiol benzoate (EB) and testosterone propionate (TP) on uterine development and responsiveness in rats.
- To explore the mechanisms underlying impaired uterine function following neonatal hormone exposure.
Main Methods:
- Neonatal rats were injected with varying doses of EB or TP on day 3 of life.
- Uterine growth response to estradiol and estrogen receptor levels were assessed on day 21.
- Ovarian weights were measured.
- Neonatal ovariectomy was performed to compare effects.
Main Results:
- Neonatal EB or TP administration significantly impaired the uterine growth response to estradiol.
- EB treatment resulted in a greater reduction in uterine responsivity compared to TP.
- Reduced uterine responsivity correlated with decreased ovarian weights and fewer available estrogen binding sites in the uterus.
- Neonatal ovariectomy mimicked the effects of neonatal estrogenization on the uterus.
Conclusions:
- Neonatal exposure to EB and TP adversely affects uterine development and estrogen responsiveness in a dose-dependent manner.
- The observed effects are likely mediated by reduced estrogen receptor availability and nuclear retention.
- Endogenous estrogen secretion during infancy is crucial for proper uterine development and establishing a functionally competent uterus.
Abstract:
Injection of neonatal rats on day 3 after birth with a single dose of 5 microgram or 100 microgram estradiol benzoate (EB) or 30 microgram or 1,250 microgram testosterone propionate (TP) drastically impairs the development of uterine growth response to exogenous estradiol on day 21 of life. Reduction of uterine responsivity was augmented by EB treatment compared to TP treatment. This may be explained by an apparent reduction in available cytoplasmic estrogen binding sites in the uterus with a concomitant decrease in nuclear retention of the receptor-estrogen complex which was in addition to the effect upon estrogen-stimulated metabolic activity (glucose oxidation) resultant from either TP or EB exposure. The degree of reduced uterine responsivity at 21 days of age directly corresponds to the degree of reduction in the ovarian weights observed in the neonatally treated rats. Neonatal ovariectomy on day 3 of life also produced a uterine response syndrome characteristic of neonatal estrogenization. Thus, it is suggested that endogenous estrogen secretion during infancy may be important in end organ conditioning in the development of a functionally competent uterus.